CD20-binding polypeptide compositions

Details for Australian Patent Application No. 2004264372 (hide)

Owner Merck Patent GmbH

Inventors Williams, Stephen; Carr, Francis J.; Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2004264372

PCT Pub. Number WO2005/016969

Priority 03018480.8 14.08.03 EP; 60/520,171 14.11.03 US

Filing date 16 August 2004

Wipo publication date 24 February 2005

Acceptance publication date 29 July 2010

International Classifications

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/016969 Priority application(s): WO2005/016969

29 July 2010 Application Accepted

  Published as AU-B-2004264372

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004264382-2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders

2004264368-Oxygen-scavenging compositions and the application thereof in packaging and containers